Winton Group LTD Guardant Health, Inc. Transaction History

Winton Group LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $122,697 - $288,318	4,823 Added 98.41%	9,724 $264,000
Q3 2022 Nov 10, 2022	BUY	$43.66 - $61.0 $213,977 - $298,961	4,901 New	4,901 $264,000
Q4 2021 Feb 10, 2022	SELL	$88.71 - $120.43 $346,589 - $470,520	-3,907 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$98.77 - $132.17 $385,894 - $516,388	3,907 New	3,907 $488,000
Q2 2021 Aug 10, 2021	SELL	$109.77 - $165.68 $728,104 - $1.1 Million	-6,633 Closed	0 $0
Q1 2021 Jul 21, 2021	SELL	$127.04 - $179.1 $1,905 - $2,686	-15 Reduced 0.23%	6,633 $1.01 Million
Q4 2020 Feb 12, 2021	SELL	$99.96 - $135.93 $2.71 Million - $3.68 Million	-27,096 Reduced 80.3%	6,648 $857,000
Q3 2020 Oct 30, 2020	SELL	$80.32 - $111.8 $2.58 Million - $3.59 Million	-32,082 Reduced 48.74%	33,744 $3.77 Million
Q2 2020 Aug 05, 2020	BUY	$60.49 - $97.5 $3.29 Million - $5.3 Million	54,356 Added 473.9%	65,826 $5.34 Million
Q1 2020 May 11, 2020	BUY	$59.04 - $88.81 $677,188 - $1.02 Million	11,470 New	11,470 $798,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.14B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.